The international terazosin trial: A multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia

European Urology

Volumn 30, Issue 3, 1996, Pages 369-376

  Debruyne, F M J ^a   Witjes, W P J ^a   Fitzpatrick, J ^a   Kirby, R ^a   Kirk, D ^a   Prezioso, D ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alpha 1 blocker; Benign prostatic hyperplasia; Nocturia; Prostate specific antigen; Quality of life; Terazosin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; TERAZOSIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOCTURIA; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; URINE FLOW RATE; VERTIGO;

EID: 0029954527     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000474198     Document Type: Article

References (0)